Remy Gross

Vice President, Business Development and Technology Advancement, Buck Institute for Research on Aging

Remy spends his time between the world of biotechnology and real estate development.

Remy has successfully participated as both a developer and investor since 1999 with transactions/portfolio value currently over $500 million dollars. Remy co-founded RCP with Max Grelier in 2013 to take advantage of thoughtful, primary market placemaking into secondary markets, such as its core market Huntsville, AL. RCP has grown considerably in its short tenure with two in-fill master planned mixed-use projects CityCentre and MidCity, both in Huntsville. These two projects alone will have a total developed value of 1.3Bn once completed. Additionally, RCP is paving the way for new and novel ESG elements in Alabama and the southeast, including the first net zero multi-family development.

In addition to his real estate endeavors, Remy is actively engaged in new start-ups in the biotech industry. A chemist by training, Remy was instrumental in the building of Shearwater Corporation as its VP, Operations (sold to Inhale Therapeutic Systems, Inc. in 2001). Remy is the Vice President, Business Development at the Buck Institute for Research on Aging in Novato, California, a rapidly growing non-profit institute. Remy took the Technology Transfer office at the Buck from having no licenses/partnerships to licensing out over 90% of its patent portfolio and creating an average of two capitalized start-up companies per year from the novel science being performed at Buck. Remy brings in sponsored research for novel science in excess of 10M/year for the institute and done strategic licensing transactions with Astellas, Calico, Astera and many others. He has founded or represented parties in multiple venture and angel-backed companies. He has advised and helped create multiple new biopharmaceutical startups at Buck, such as Unity Biotechnology (UBX), Aeovian Therapeutics (over 40M raised), BhB Therapeutics (over 40M raised) and multiple others.

Remy sits on the board of BhB Therapeutics, Napa Therapeutics and Selah Therapeutics. Remy acts as a strategic advisor to Serina Therapeutics, Inc.

Most importantly, Remy is married with three children who are all launched and in grad school or working on the east coast. He enjoys fitness of any kind, reading and adding value wherever he can.